NCPI
NIH Cloud PlatformInteroperability Effort
searchclose
YouYubeGitHubSlack

Study

arrow_backDatasets

Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)

phs002752.v1.p1dbGapdbGap FHIR

Description

The Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) is a multicenter, randomized, single blind, two-arm, placebo controlled Phase III trial with blinded outcome assessments to establish the safety and efficacy of single dose of convalescent plasma for preventing the progression from mild to severe COVID-19 illness.

Summary

PlatformsBDC
Consent CodesGRU
Focus / DiseasesCOVID-19
Study DesignClinical Trial
Data Types--
Subjects511

Applying For Access

dbGaP FAQdbGaP Access Request Video Tutorial